Valvular Dysfunction and Carotid, Subclavian, and Coronary Artery Disease in Survivors of Hodgkin Lymphoma Treated with Radiation Therapy

JAMA

Volumn 290, Issue 21, 2003, Pages 2831-2837

  Hull, Matthew C ^a   Morris, Christopher G ^a   Pepine, Carl J ^a   Mendenhall, Nancy Price ^a  

^a Department of Radiation Oncology ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; AORTA STENOSIS; ARTICLE; CANCER RADIOTHERAPY; CAROTID ARTERY DISEASE; CHILD; CONFIDENCE INTERVAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; HEALTH SURVEY; HEART VALVE SURGERY; HODGKIN DISEASE; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; INTERVENTIONAL RADIOLOGY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIVARIATE ANALYSIS; PATIENT REFERRAL; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RADIATION DOSE; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SUBCLAVIAN ARTERY; TRANSLUMINAL CORONARY ANGIOPLASTY; VALVULAR HEART DISEASE;

EID: 0344667638     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.290.21.2831     Document Type: Article

References (39)

1. Cohn KE, Stewart JR, Fajardo LF, Hancock EW. Heart disease following radiation. Medicine (Baltimore). 1967;46:281-298.
2. Prentice RT. Myocardial infarction following radiation. Lancet. 1965;2:388.
3. Henry-Amar M, Hayat M, Meerwaldt JH, et al, for the EORTC Lymphoma Cooperative Group. Causes of death after therapy for early stage Hodgkin's disease entered on EORTC protocols. Int J Radiat Oncol Biol Phys. 1990;19:1155-1157.
4. Vaughan Hudson B, Vaughan Hudson G, Linch DC, Anderson L. Late mortality in young BNLI patients cured of Hodgkin's disease. Ann Oncol. 1994;5(suppl 2): 65-66.
5. Mauch PM, Kalish LA, Marcus KC, et al. Long-term survival in Hodgkin's disease: relative impact of mortality, second tumors, infection and cardiovascular disease. Cancer J Sci Am. 1995;1:33.
6. Hoppe RT. Hodgkin's disease: complications of therapy and excess mortality. Ann Oncol. 1997;8 (suppl 1):115-118.
7. Boivin JF. Coronary artery disease mortality in patients treated for Hodgkin's disease. Cancer. 1992; 69:1241-1247.
8. Cosset JM, Henry-Amar M, Pellae-Cosset B, et al. Pericarditis and myocardial infarctions after Hodgkin's disease therapy. Int J Radiat Oncol Biol Phys. 1991; 21:447-449.
9. Glanzmann C, Kaufmann P, Jenni R, Hess OM, Huguenin P. Cardiac risk after mediastinal irradiation for Hodgkin's disease. Radiother Oncol. 1998;46:51-62.
10. Perrault DJ, Levy M, Herman JD, et al. Echocardiographic abnormalities following cardiac radiation. J Clin Oncol. 1985;3:546-551.
11. Pohjola-Sintonen S, Totterman KJ, Salmo M, Siltanen P. Late cardiac effects of mediastinal radiotherapy in patients with Hodgkin's disease. Cancer. 1987;60:31-37.
12. Lund MB, Ihlen H, Voss BM, et al. Increased risk of heart valve regurgitation after mediastinal radiation for Hodgkin's disease: an echocardiographic study. Heart. 1996;75:591-595.
13. Gustavsson A, Eskilsson J, Landberg T, et al. Late cardiac effects after mantle radiotherapy in patients with Hodgkin's disease. Ann Oncol. 1990;1:355-361.
14. Kreuser ED, Voller H, Behles C, et al. Evaluation of late cardiotoxicity with pulsed Doppler echocardiography in patients treated for Hodgkin's disease. Br J Haematol. 1993;84:615-622.
15. Elerding SC, Fernandez RN, Grotta JC, Lindberg RD, Causay LC, McMurtrey MJ. Carotid artery disease following external cervical irradiation. Ann Surg. 1981;194:609-615.
16. King U, Hasnain SN, Webb JA, et al. Asymptomatic carotid arterial disease in young patients following neck radiation therapy for Hodgkin lymphoma. Radiology. 1999;213:167-172.
17. Fletcher GH. Textbook of Radiotherapy. 3rd ed. Philadelphia, Pa: Lea & Febiger; 1980.
18. Mendenhall NP, Rodrigue LL, Moore-Higgs GJ, Marcus RB Jr, Million RR. The optimal dose of radiation in Hodgkin's disease: an analysis of clinical and treatment factors affecting in-field disease control. Int J Radiat Oncol Biol Phys. 1999;44:551-561.
19. SAS OnlineDoc [computer program]. Version 8. Cary, NC: SAS Institute Inc; 1999.
20. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53: 457-481.
21. National Hospital Discharge Survey Multi-Year Data File 1979-1999, [serial on CD-ROM]. Atlanta, Ga: Centers for Disease Control and Prevention, National Center for Health Statistics; 2001. Series 13, No. 19A.
22. Surveillance, Epidemiology, and End Results (SEER) Program Public-Use Data. [based on Nov 2001 submission]. 2002. National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch.
23. King V, Constine LS, Clark D, et al. Symptomatic coronary artery disease after mantle irradiation for Hodgkin's disease. Int J Radiat Oncol Biol Phys. 1996; 36:881-889.
24. Cox DR. Regression models and life tables. J R Stat Soc Series B (Methodological). 1972;34:187-220.
25. Hancock SL. Cardiovascular late effects after treatment of Hodgkin's disease. In: Mauch PM, Armitage JO, Diehl V, Hoppe RT, Weiss LM, eds. Hodgkin's Disease. Philadelphia, Pa: Lippincott Williams & Wilkins; 1999:647-659.
26. Lee CK, Aeppli D, Nierengarten ME. The need for long-term surveillance for patients treated with curative radiotherapy for Hodgkin's disease: University of Minnesota experience. Int J Radiat Oncol Biol Phys. 2000;48:169-179.
27. Reinders JG, Heijmen BJ, Olofsen-van Acht MJ, van Putten WL, Levendag PC. Ischemic heart disease after mantlefield irradiation for Hodgkin's disease in long-term follow-up. Radiother Oncol. 1999;51:35-42.
28. Byhardt R, Brace K, Ruckdeschel J, Chang P, Martin R, Wiernik P. Dose and treatment factors in radiation-related pericardial effusion associated with the mantle technique for Hodgkin's disease. Cancer. 1975; 35:795-802.
29. Mendenhall NP. Hodgkin's disease. In: Gunderson LL, Tepper JE, eds. Clinical Radiation Oncology. New York, NY: Churchill Livingstone; 2000:1123-1157.
30. Morton DL, Glancy DL, Joseph WL, Adkins PC. Management of patients with radiation-induced pericarditis with effusion: a note on the development of aortic regurgitation in two of them. Chest. 1973;64: 291-297.
31. Cheng SW, Ting ACW, Lam LK, Wei WI. Carotid stenosis after radiotherapy for nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg. 2000; 126:517-521.
32. Conomy JP, Kellermeyer RW. Delayed cerebrovascular consequences of therapeutic radiation: a clinicopathologic study of a stroke associated with radiation-related carotid arteriopathy. Cancer. 1975;36: 1702-1708.
33. Dubec JJ, Munk PL, Tsang V, et al. Carotid artery stenosis in patients who have undergone radiation therapy for head and neck malignancy. Br J Radiol. 1998;71:872-875.
34. Houdart E, Mounayer C, Chapot R, Saint-Maurice JP, Merland JJ. Carotid stenting for radiation-induced stenosis: a report of 7 cases. Stroke. 2001; 32:118-121.
35. Lam WW, Leung SF, So NM, et al. Incidence of carotid stenosis in nasopharyngeal carcinoma patients after radiotherapy. Cancer. 2001;92:2357-2363.
36. Ahuja A, Blatt GL, Guterman LR, Hopkins LN. Angioplasty for symptomatic radiation-induced extracranial carotid artery stenosis: case report. Neurosurgery. 1995;36:399-403.
37. Santoro A, Bristot R, Paolini S, Di Stefano D, Cantore G. Radiation injury involving the internal carotid artery: report of two cases. J Neurosurg Sci. 2000;44: 159-164.
38. Achenbach S, Moshage W, Ropers D, Nossen J, Daniel WG. Value of electron-beam computed tomography for the noninvasive detection of high-grade coronary-artery stenoses and occlusions. N Engl J Med. 1998;339:1964-1971.
39. Kim WY, Danias PG, Stuber M, et al. Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl J Med. 2001;345:1863-1869.